176 related articles for article (PubMed ID: 29344278)
1. Potent peptide-conjugated silicon phthalocyanines for tumor photodynamic therapy.
Liu Q; Pang M; Tan S; Wang J; Chen Q; Wang K; Wu W; Hong Z
J Cancer; 2018; 9(2):310-320. PubMed ID: 29344278
[TBL] [Abstract][Full Text] [Related]
2. cRGD Peptide-Conjugated Pyropheophorbide-a Photosensitizers for Tumor Targeting in Photodynamic Therapy.
Li W; Tan S; Xing Y; Liu Q; Li S; Chen Q; Yu M; Wang F; Hong Z
Mol Pharm; 2018 Apr; 15(4):1505-1514. PubMed ID: 29502410
[TBL] [Abstract][Full Text] [Related]
3. A biotin receptor-targeted silicon(IV) phthalocyanine for in vivo tumor imaging and photodynamic therapy.
Li K; Dong W; Liu Q; Lv G; Xie M; Sun X; Qiu L; Lin J
J Photochem Photobiol B; 2019 Jan; 190():1-7. PubMed ID: 30453160
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic effects of new silicon phthalocyanines: in vitro studies utilizing rat hepatic microsomes and human erythrocyte ghosts as model membrane sources.
Zaidi SI; Agarwal R; Eichler G; Rihter BD; Kenney ME; Mukhtar H
Photochem Photobiol; 1993 Aug; 58(2):204-10. PubMed ID: 8415911
[TBL] [Abstract][Full Text] [Related]
5. Conjugate of biotin with silicon(IV) phthalocyanine for tumor-targeting photodynamic therapy.
Li K; Qiu L; Liu Q; Lv G; Zhao X; Wang S; Lin J
J Photochem Photobiol B; 2017 Sep; 174():243-250. PubMed ID: 28802175
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of peptide-conjugated phthalocyanine photosensitizers with highly hydrophilic modifications.
Li F; Liu Q; Liang Z; Wang J; Pang M; Huang W; Wu W; Hong Z
Org Biomol Chem; 2016 Apr; 14(13):3409-22. PubMed ID: 26956169
[TBL] [Abstract][Full Text] [Related]
7. Folate-Targeted Polyethylene Glycol-Modified Photosensitizers for Photodynamic Therapy.
Liu Q; Wang J; Li S; Li G; Chen Q; Hong Z
J Pharm Sci; 2019 Jun; 108(6):2102-2111. PubMed ID: 30677421
[TBL] [Abstract][Full Text] [Related]
8. Multimerization Increases Tumor Enrichment of Peptide⁻Photosensitizer Conjugates.
Zhao J; Li S; Jin Y; Wang JY; Li W; Wu W; Hong Z
Molecules; 2019 Feb; 24(4):. PubMed ID: 30823562
[TBL] [Abstract][Full Text] [Related]
9. Highly water-soluble and tumor-targeted photosensitizers for photodynamic therapy.
Li Y; Wang J; Zhang X; Guo W; Li F; Yu M; Kong X; Wu W; Hong Z
Org Biomol Chem; 2015 Jul; 13(28):7681-94. PubMed ID: 26082999
[TBL] [Abstract][Full Text] [Related]
10. Preparation and in vitro photodynamic activity of novel silicon(IV) phthalocyanines conjugated to serum albumins.
Huang JD; Lo PC; Chen YM; Lai JC; Fong WP; Ng DK
J Inorg Biochem; 2006 May; 100(5-6):946-51. PubMed ID: 16412511
[TBL] [Abstract][Full Text] [Related]
11. New amphiphilic silicon(IV) phthalocyanines as efficient photosensitizers for photodynamic therapy: synthesis, photophysical properties, and in vitro photodynamic activities.
Lo PC; Huang JD; Cheng DY; Chan EY; Fong WP; Ko WH; Ng DK
Chemistry; 2004 Oct; 10(19):4831-8. PubMed ID: 15372681
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and photodynamic activities of integrin-targeting silicon(IV) phthalocyanine-cRGD conjugates.
Zheng BY; Yang XQ; Zhao Y; Zheng QF; Ke MR; Lin T; Chen RX; Ho KKK; Kumar N; Huang JD
Eur J Med Chem; 2018 Jul; 155():24-33. PubMed ID: 29852329
[TBL] [Abstract][Full Text] [Related]
13. The synthesis of 64Cu-chelated porphyrin photosensitizers and their tumor-targeting peptide conjugates for the evaluation of target cell uptake and PET image-based pharmacokinetics of targeted photodynamic therapy agents.
Mukai H; Wada Y; Watanabe Y
Ann Nucl Med; 2013 Aug; 27(7):625-39. PubMed ID: 23605059
[TBL] [Abstract][Full Text] [Related]
14. The synthesis, photophysical and photobiological properties and in vitro structure-activity relationships of a set of silicon phthalocyanine PDT photosensitizers.
He J; Larkin HE; Li YS; Rihter D; Zaidi SI; Rodgers MA; Mukhtar H; Kenney ME; Oleinick NL
Photochem Photobiol; 1997 Mar; 65(3):581-6. PubMed ID: 9077144
[TBL] [Abstract][Full Text] [Related]
15. New Targeted Gold Nanorods for the Treatment of Glioblastoma by Photodynamic Therapy.
Youssef Z; Yesmurzayeva N; Larue L; Jouan-Hureaux V; Colombeau L; Arnoux P; Acherar S; Vanderesse R; Frochot C
J Clin Med; 2019 Dec; 8(12):. PubMed ID: 31847227
[TBL] [Abstract][Full Text] [Related]
16. The Surprisingly Positive Effect of Zinc-Phthalocyanines With High Photodynamic Therapy Efficacy of Melanoma Cancer.
Castro KADF; Prandini JA; Biazzotto JC; Tomé JPC; da Silva RS; Lourenço LMO
Front Chem; 2022; 10():825716. PubMed ID: 35360535
[TBL] [Abstract][Full Text] [Related]
17. A hypoxia responsive silicon phthalocyanine containing naphthquinone axial ligands for photodynamic therapy activity.
Nwahara N; Abrahams G; Mack J; Prinsloo E; Nyokong T
J Inorg Biochem; 2023 Feb; 239():112078. PubMed ID: 36435091
[TBL] [Abstract][Full Text] [Related]
18. Silicon Phthalocyanines Axially Disubstituted with Erlotinib toward Small-Molecular-Target-Based Photodynamic Therapy.
Chen JJ; Huang YZ; Song MR; Zhang ZH; Xue JP
ChemMedChem; 2017 Sep; 12(18):1504-1511. PubMed ID: 28776965
[TBL] [Abstract][Full Text] [Related]
19. Water-soluble phthalocyanine photosensitizers for photodynamic therapy.
Ömeroğlu İ; Durmuş M
Turk J Chem; 2023; 47(5):837-863. PubMed ID: 38173755
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and characterization of novel zinc phthalocyanines as potential photosensitizers for photodynamic therapy of cancers.
Moeno S; Krause RW; Ermilov EA; Kuzyniak W; Höpfner M
Photochem Photobiol Sci; 2014 Jun; 13(6):963-70. PubMed ID: 24752676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
